-
Sep 28, 2018, 11:53 am76 pts
ENNMelbourne scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why some patients respond to the drugs, while others do not.
Trending Today on EcoTopical
Welcome to EcoTopical Your daily eco-friendly green news aggregator.
Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.
Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.

![Volkswagen’s entry-level EV spotted as a hot hatch R-Line model [Video]](https://electrek.co/wp-content/uploads/sites/3/2026/03/Volkswagen-ID.Polo-R-Line.jpeg?quality=82&strip=all)


![Kia’s cheapest EV looks like a baby Seltos [Video]](https://electrek.co/wp-content/uploads/sites/3/2026/03/Kia-EV2-Seltos-electric.jpeg?quality=82&strip=all)












